|
Quotes & Info
|
| PSTI > SEC Filings for PSTI > Form 8-K on 15-Jan-2013 | All Recent SEC Filings |
15-Jan-2013
Other Events
On January 15, 2013, the registrant announced that it had received an approval from the Paul-Ehrlich-Institute, the medical regulatory body for biological medicinal products for the Federal Republic of Germany, to commence a Phase II study using PLX-PAD cells in patients suffering from intermittent claudication.
|
|